Feedback / Questions
Campath (alemtuzumab) - Sanofi
Folotyn (pralatrexate) - Aurobindo
HuMax-CD4 (zanolimumab) - Emergent Biosolutions
Keytruda (pembrolizumab) - Merck (MSD)
acimtamig (AFM13) - Affimed
https://library.ehaweb.org/eha/2025/eha2025-congress/4161026/abat.khan.comparative.efficacy.of.therapeutic.approaches.in.relapsed.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D2882%2Aot_id%3D31553%2Amarker%3D5844%2Afeatured%3D19595
Abat Khan; Hira Habib; Ayesha Butt; Haneen Kamran; Muhammad Hamza; Hunaina Aman; Aima javaid; Hiba Shaukat; Moazzam Shahzad; Jose Sandoval-sus
May 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next